ReviewAmerican journal of cancer research2015

MYC-xing it up with PIK3CA mutation and resistance to PI3K inhibitors: summit of two giants in breast cancers.

Nandini Dey et al.PubMed ↗Full text ↗

No numbers read from the abstract.